SNTA Do not despair and see double your money Stron Buy
Sentiment: Strong Buy
Did you know that there are services on the internet that allow you to follow the prices of an unlimited number of stocks without having to "hang around" anywhere?
You should get around the interwebs a bit more, there's some tremendous stuff out there!
Thank you for re-wording, and correct, that is what I beleive. I've been following SNTA for roughly 2 years and they seem to be more and more refined for a production platform as time has gone on. This is all a part of establishing a stable base.
They just announced they have nearly $98 million in cash... why does the company have to raise money? We are now at a 6 year low due entirely to their "no confidence" pricing.
hey idiol pumping loser, you have been saying SNTA is going up every day and all i see is going down....
By the way, what happened to the 2.18 bottom loser?
It's not a firesale but a means to raise capital for bringing product to market. It's value is in it's speculative ability to produce a viable cancer drug. If it already had a sellable product we would'nt be discussing a public offering. It'll trade higher pretty soon as half of the 22 million have already been bought.
"BUYOUT CANDIDATE "
Telesta Therapeuctis (TST.TO) (OTC : BNHLF)
Market Cap: $49 M
We (Euro Pacific Capital) are initiating coverage on Telesta Therapeutics (formerly Bioniche Life Sciences) with a Speculative BUY rating and one-year target price of $1.25. The firm’s lead non-muscle invasive bladder cancer biologic MCNA (described below) already performed well in Phase III testing, well enough to be FDA approved by next year in our view, and our model is primarily derived from free cash flow projections in global markets for this imminently partnerable (and acquirable) clinical asset. Investment Highlights Attractive oncology drug developer for which already-published Phase III data mitigates clinical risk .
Why would this trade at a significant premium over the secondary offering? Usually it would be at or slightly below and this is staying above $1.90? Everyone seems blindsided by the timing.